Macromolecule release from monodisperse PLG microspheres: control of release rates and investigation of release mechanism
C Berkland, E Pollauf, C Raman, R Silverman… - Journal of …, 2007 - Elsevier
Novel macromolecular therapeutics such as peptides, proteins, and DNA are advancing
rapidly toward the clinic. Because of typically low oral bioavailability, macromolecule …
rapidly toward the clinic. Because of typically low oral bioavailability, macromolecule …
Macromolecule release from monodisperse PLG microspheres: control of release rates and investigation of release mechanism.
C Berkland, E Pollauf, C Raman… - Journal of …, 2007 - europepmc.org
Novel macromolecular therapeutics such as peptides, proteins, and DNA are advancing
rapidly toward the clinic. Because of typically low oral bioavailability, macromolecule …
rapidly toward the clinic. Because of typically low oral bioavailability, macromolecule …
[PDF][PDF] Macromolecule Release from Monodisperse PLG Microspheres: Control of Release Rates and Investigation of Release Mechanism
C BERKLAND, E POLLAUF, C RAMAN… - JOURNAL OF …, 2007 - academia.edu
Novel macromolecular therapeutics such as peptides, proteins, and DNA are advancing
rapidly toward the clinic. Because of typically low oral bioavailability, macromolecule …
rapidly toward the clinic. Because of typically low oral bioavailability, macromolecule …
[引用][C] Macromolecule Release from Monodisperse PLG Microspheres: Control of Release Rates and Investigation of Release Mechanism
C Berkland, E Pollauf, C Raman, R Silverman… - Journal of …, 2007 - cir.nii.ac.jp
Macromolecule Release from Monodisperse PLG Microspheres: Control of Release Rates
and Investigation of Release Mechanism | CiNii Research CiNii 国立情報学研究所 学術情報 …
and Investigation of Release Mechanism | CiNii Research CiNii 国立情報学研究所 学術情報 …
Macromolecule Release from Monodisperse PLG Microspheres: Control of Release Rates and Investigation of Release Mechanism
C Berkland, E Pollauf, C Raman… - Journal of …, 2007 - jpharmsci.org
Novel macromolecular therapeutics such as peptides, proteins, and DNA are advancing
rapidly toward the clinic. Because of typically low oral bioavailability, macromolecule …
rapidly toward the clinic. Because of typically low oral bioavailability, macromolecule …
Macromolecule release from monodisperse PLG microspheres: Control of release rates and investigation of release mechanism
C Berkland, E Pollauf, C Raman… - Journal of …, 2007 - Wiley Online Library
Novel macromolecular therapeutics such as peptides, proteins, and DNA are advancing
rapidly toward the clinic. Because of typically low oral bioavailability, macromolecule …
rapidly toward the clinic. Because of typically low oral bioavailability, macromolecule …
[引用][C] Macromolecule release from monodisperse PLG microspheres: Control of release rates and investigation of release mechanism
C BERKLAND, E POLLAUF, C RAMAN… - Journal of …, 2007 - pascal-francis.inist.fr
Macromolecule release from monodisperse PLG microspheres : Control of release rates
and investigation of release mechanism CNRS Inist Pascal-Francis CNRS Pascal and …
and investigation of release mechanism CNRS Inist Pascal-Francis CNRS Pascal and …
Macromolecule release from monodisperse PLG microspheres: control of release rates and investigation of release mechanism
C Berkland, E Pollauf, C Raman… - Journal of …, 2007 - pubmed.ncbi.nlm.nih.gov
Novel macromolecular therapeutics such as peptides, proteins, and DNA are advancing
rapidly toward the clinic. Because of typically low oral bioavailability, macromolecule …
rapidly toward the clinic. Because of typically low oral bioavailability, macromolecule …
Macromolecule release from monodisperse PLG microspheres: Control of release rates and investigation of release mechanism
C Berkland, E Pollauf, C Raman… - Journal of …, 2007 - experts.illinois.edu
Novel macromolecular therapeutics such as peptides, proteins, and DNA are advancing
rapidly toward the clinic. Because of typically low oral bioavailability, macromolecule …
rapidly toward the clinic. Because of typically low oral bioavailability, macromolecule …